Nektar Therapeutics
ADENOSINE 2 RECEPTOR ANTAGONISTS
Last updated:
Abstract:
The instant disclosure provides novel adenosine receptor antagonist compounds, compositions, methods of making and methods of using. In a further aspect, a method of treating a subject in need thereof, comprising administering a therapeutically effective amount of any one or more of the compounds described herein. In some embodiments, the subject has cancer and the method is a method of treating cancer.
Status:
Application
Type:
Utility
Filling date:
1 May 2020
Issue date:
28 Jul 2022